Modelling the health-economic impact of the next influenza pandemic in The Netherlands

Vaccine

Volumn 24, Issue 44-46, 2006, Pages 6756-6760

  Hak, E ^a   Meijboom, M J ^a   Buskens, E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Economics; Health care sector; Influenza; Models; Prevention; Primary care

Indexed keywords

INFLUENZA VACCINE;

AGE DISTRIBUTION; ARTICLE; COST BENEFIT ANALYSIS; ECONOMIC ASPECT; HEALTH CARE DELIVERY; HEALTH ECONOMICS; HOSPITALIZATION; HUMAN; INFLUENZA; NETHERLANDS; POPULATION AND POPULATION RELATED PHENOMENA; POPULATION MODEL; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADULT; AMBULATORY CARE; COST-BENEFIT ANALYSIS; DISASTER PLANNING; DISEASE OUTBREAKS; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; NETHERLANDS;

EID: 33846263517     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.065     Document Type: Article

References (15)

1. World Health Organisation, Department of Communicable Disease Surveillance and Response. Avian Influenza: Assessing the Pandemic Threat, 2005 [available from: http://www.who.int/csr/disease/influenza/].
2. Ungchusak K., Auewarakul P., Dowell S.F., Kitphati R., Auwanit W., Puthavathana P., et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 352 (2005) 333-340
3. De Jong M.D., Bach V.C., Phan T.O., VO M.H., Tran T.T., Nguyen B.H., et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 352 (2005) 686-691
4. Dutch Health Council. Use of antiviral drugs and other means during an influenza pandemic (2005), Gezondheidsraad, The Hague [no. 2005/05]
5. Tran T.H., Nguyen T.L., Nguyen T.D., et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 350 (2004) 1179-1188
6. Ferguson N.M., Cummings D.A., Cauchemez S., Fraser C., Riley C., Meeyai A., et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437 (2005) 209-214
7. Meltzer M.I., Cox N.J., and Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis 5 (1999) 659-671
8. Van Genugten M.L., Heijnen M.A., and Jager J.C. Pandemic influenza and healthcare demand in the Netherlands: scenario analysis. Emerg Infect Dis 9 (2003) 531-538
9. Hak E., Buskens E., Van Essen G.A., De Bakker D.H., Grobbee D.E., Tacken M.A., et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 165 (2005) 274-280
10. Nguyen-Van-Tam J.S., and Hampson A.W. The epidemiology and clinical impact of pandemic influenza. Vaccine 21 (2003) 1762-1768
11. Glezen W.P. Emerging infections: pandemic influenza. Epidemiol Rev 18 (1996) 64-76
12. Hoogenveen R.T., Gijsen R., van Genugten M.L.L., Kommer G.J., Schouten J.S.A.G., and de Hollander A.E.M. Dutch DisMod: constructing a set of consistent data for chronic disease modelling (2000), RIVM, editor, Bilthoven
13. College voor Zorgverzekeringen. Dutch guidelines for pharmacoeconomic research (1999), College voor Zorgverzekeringen, Amstelveen, the Netherlands
14. Oostenbrink J., Koopmanschap M.A., and Rutten F.F.H. Handleiding voor kostenonderzoek; methoden en richtlijnprijzen voor economische evaluaties in de gezondheidszorg (2004), College voor zorgverzekeringen, Amstelveen
15. Simonsen L., Clarke M.J., Schonberger L.B., Arden N.H., Cox N.J., and Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 178 (1998) 53-60